Virgin Galactic Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Virgin Galactic Holdings, Inc. (NYSE: SPCE) reported its financial results for Q4 and full year 2022, revealing a net loss of $500 million for the year, up from $353 million in 2021. Q4 2022 net loss was $151 million, worsening from a $81 million loss in Q4 2021. Despite challenges, the company has a strong cash position with $980 million as of December 31, 2022. Operating activities consumed $380 million in cash over the year. The company is on track to launch commercial services in Q2 2023 following successful validation flights. Significant investments were made in R&D, totaling $314 million for the full year, highlighting ongoing development efforts.
- Strong cash position of $980 million as of December 31, 2022.
- Successful validation flights completed, indicating readiness for commercial service in Q2 2023.
- Net loss of $500 million for full year 2022, a $147 million increase from 2021.
- Operating activities consumed $380 million in cash, significantly higher than $231 million in 2021.
- Adjusted EBITDA of $(431) million for the year, worsening from $(245) million in 2021.
- Commercial Service Remains on Track for Q2 2023
- Enhancements to VMS Eve and VSS Unity Complete
- VMS Eve Has Returned to Spaceport America to Begin Flights with VSS Unity
Fourth Quarter 2022 Financial Highlights
-
Cash position remains strong, with cash and cash equivalents and marketable securities of
as of$980 million December 31, 2022 . -
Net loss of
, compared to a$151 million net loss in the fourth quarter of 2021.$81 million -
GAAP selling, general and administrative expenses of
, compared to$47 million in the fourth quarter of 2021. Non‐GAAP selling, general and administrative expenses of$38 million in the fourth quarter of 2022, compared to$39 million in the fourth quarter of 2021.$29 million -
GAAP research and development expenses of
, compared to$103 million in the fourth quarter of 2021. Non‐GAAP research and development expenses of$40 million in the fourth quarter of 2022, compared to$99 million in the fourth quarter of 2021.$36 million -
Adjusted EBITDA totaled
, compared to$(133) million in the fourth quarter of 2021.$(65) million -
Net cash used in operating activities totaled
, compared to$131 million in the fourth quarter of 2021.$65 million -
Cash paid for capital expenditures totaled
, compared to$4 million in the fourth quarter of 2021.$2 million -
Free cash flow totaled
, compared to$(135) million in the fourth quarter of 2021.$(67) million -
Generated
in gross proceeds through the issuance of 0.7 million shares of common stock as part of the Company's at-the-market offering program announced on$3.8 million August 4, 2022 .
Full Year 2022 Financial Highlights
-
Net loss of
, compared to a$500 million net loss in 2021.$353 million -
GAAP selling, general and administrative expenses of
, compared to$175 million in 2021. Non-GAAP selling, general and administrative expenses of$167 million , compared to$143 million in 2021.$121 million -
GAAP research and development expenses of
, compared to$314 million in 2021. Non-GAAP research and development expenses of$144 million , compared to$300 million in 2021.$129 million -
Adjusted EBITDA totaled
, compared to$(431) million in 2021.$(245) million -
Net cash used in operating activities totaled
, compared to$380 million in 2021.$231 million -
Cash paid for capital expenditures totaled
, compared to$16 million in 2021.$5 million -
Free cash flow totaled
, compared to$(397) million in 2021.$(235) million -
Generated
in gross proceeds through the issuance of 16.3 million shares of common stock as part of the Company's at-the-market offering program announced on$103.3 million August 4, 2022 . -
Generated
in gross proceeds through the issuance of convertible senior notes on$425 million January 19, 2022 .
Recent Updates and Full Year Business Highlights
- Commercial service remains on track for Q2 2023.
-
On
November 2, 2022 , announcedBell Textron andQarbon Aerospace as primary suppliers to provide major subassemblies forDelta Class spaceships. -
On
August 2, 2022 , announced land inNew Mexico secured for a new astronaut campus and training facility. -
On
July 14, 2022 , announced new final assembly manufacturing facility inMesa, Arizona for the Delta Class spaceships. -
On
July 6, 2022 , announced agreement withAurora Flight Sciences to build the next generation motherships.
Financial Guidance
The following forward-looking statements reflect our expectations for the first quarter of 2023 as of
-
Forecasted free cash flow for the first quarter of 2023 is expected to be in the range of
to$(135) million .$(145) million
Non-GAAP Financial Measures
In addition to the Company's results prepared in accordance with generally accepted accounting principles in
Conference Call Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our spaceflight systems, expected flight schedule, timing of commercial launch, completion of our Delta class spaceship and motherships, our objectives for future operations and the Company’s financial forecasts, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended
Fourth Quarter 2022 Financial Results |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Loss |
||||||||||||||||
(In thousands, except for per share amounts) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
|
|
|
||||||||||
Revenue |
|
$ |
869 |
|
|
$ |
141 |
|
|
$ |
2,312 |
|
|
$ |
3,292 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Customer experience |
|
|
1,169 |
|
|
|
2 |
|
|
|
1,906 |
|
|
|
272 |
|
Selling, general and administrative |
|
|
47,298 |
|
|
|
38,311 |
|
|
|
175,118 |
|
|
|
166,814 |
|
Research and development |
|
|
102,596 |
|
|
|
40,226 |
|
|
|
314,174 |
|
|
|
144,223 |
|
Depreciation and amortization |
|
|
3,117 |
|
|
|
2,883 |
|
|
|
11,098 |
|
|
|
11,518 |
|
Total operating expenses |
|
|
154,180 |
|
|
|
81,422 |
|
|
|
502,296 |
|
|
|
322,827 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating loss |
|
|
(153,311 |
) |
|
|
(81,281 |
) |
|
|
(499,984 |
) |
|
|
(319,535 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Interest income |
|
|
6,175 |
|
|
|
423 |
|
|
|
12,502 |
|
|
|
1,208 |
|
Interest expense |
|
|
(3,206 |
) |
|
|
(6 |
) |
|
|
(12,130 |
) |
|
|
(25 |
) |
Change in fair value of warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(34,650 |
) |
Other income, net |
|
|
51 |
|
|
|
72 |
|
|
|
58 |
|
|
|
182 |
|
Loss before income taxes |
|
|
(150,291 |
) |
|
|
(80,792 |
) |
|
|
(499,554 |
) |
|
|
(352,820 |
) |
Income tax expense |
|
|
529 |
|
|
|
5 |
|
|
|
598 |
|
|
|
79 |
|
Net loss |
|
|
(150,820 |
) |
|
|
(80,797 |
) |
|
|
(500,152 |
) |
|
|
(352,899 |
) |
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment |
|
|
167 |
|
|
|
118 |
|
|
|
(146 |
) |
|
|
129 |
|
Unrealized gain (loss) on marketable securities |
|
|
2,916 |
|
|
|
(1,566 |
) |
|
|
(5,311 |
) |
|
|
(2,003 |
) |
Total comprehensive loss |
|
$ |
(147,737 |
) |
|
$ |
(82,245 |
) |
|
$ |
(505,609 |
) |
|
$ |
(354,773 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
$ |
(0.55 |
) |
|
$ |
(0.31 |
) |
|
$ |
(1.89 |
) |
|
$ |
(1.43 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
|
274,902 |
|
|
|
257,888 |
|
|
|
263,947 |
|
|
|
247,619 |
|
|
||||||||
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In thousands) |
||||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
2022 |
|
|
|
2021 |
|
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
302,291 |
|
|
$ |
524,481 |
|
Restricted cash |
|
|
40,336 |
|
|
|
25,549 |
|
Marketable securities, short-term |
|
|
606,716 |
|
|
|
79,418 |
|
Inventories |
|
|
24,043 |
|
|
|
29,668 |
|
Prepaid expenses and other current assets |
|
|
28,228 |
|
|
|
19,476 |
|
Total current assets |
|
|
1,001,614 |
|
|
|
678,592 |
|
Marketable securities, long-term |
|
|
30,392 |
|
|
|
301,463 |
|
Property, plant and equipment, net |
|
|
53,658 |
|
|
|
47,498 |
|
Other non-current assets |
|
|
54,274 |
|
|
|
41,281 |
|
Total assets |
|
$ |
1,139,938 |
|
|
$ |
1,068,834 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
|
16,326 |
|
|
|
9,237 |
|
Accrued liabilities |
|
|
61,848 |
|
|
|
28,787 |
|
Customer deposits |
|
|
102,647 |
|
|
|
90,863 |
|
Other current liabilities |
|
|
3,232 |
|
|
|
2,636 |
|
Total current liabilities |
|
|
184,053 |
|
|
|
131,523 |
|
Non-current liabilities: |
|
|
|
|
||||
Convertible senior notes, net |
|
|
415,720 |
|
|
|
— |
|
Other long-term liabilities |
|
|
59,942 |
|
|
|
43,047 |
|
Total liabilities |
|
|
659,715 |
|
|
|
174,570 |
|
Stockholders' Equity |
|
|
|
|
||||
Preferred stock |
|
|
— |
|
|
|
— |
|
Common stock |
|
|
28 |
|
|
|
26 |
|
Additional paid-in capital |
|
|
2,111,316 |
|
|
|
2,019,750 |
|
Accumulated deficit |
|
|
(1,623,795 |
) |
|
|
(1,123,643 |
) |
Accumulated other comprehensive loss |
|
|
(7,326 |
) |
|
|
(1,869 |
) |
Total stockholders' equity |
|
|
480,223 |
|
|
|
894,264 |
|
Total liabilities and stockholders' equity |
|
$ |
1,139,938 |
|
|
$ |
1,068,834 |
|
|
||||||||||||||||
|
||||||||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||||||
(In thousands) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
||||||||
Net loss |
|
$ |
(150,820 |
) |
|
$ |
(80,797 |
) |
|
$ |
(500,152 |
) |
|
$ |
(352,899 |
) |
Stock-based compensation |
|
|
11,221 |
|
|
|
13,101 |
|
|
|
45,709 |
|
|
|
61,805 |
|
Depreciation and amortization |
|
|
3,123 |
|
|
|
2,883 |
|
|
|
11,098 |
|
|
|
11,518 |
|
Amortization of debt issuance costs |
|
|
532 |
|
|
|
— |
|
|
|
1,998 |
|
|
|
— |
|
Change in fair value of warrant liability |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34,650 |
|
Other non-cash items |
|
|
538 |
|
|
|
53 |
|
|
|
10,800 |
|
|
|
11 |
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
|
||||||||
Inventories |
|
|
(1,192 |
) |
|
|
(363 |
) |
|
|
5,625 |
|
|
|
815 |
|
Other current and non-current assets |
|
|
(5,063 |
) |
|
|
(9,807 |
) |
|
|
(2,810 |
) |
|
|
(3,465 |
) |
Accounts payable and accrued liabilities |
|
|
11,323 |
|
|
|
6,111 |
|
|
|
35,151 |
|
|
|
7,935 |
|
Customer deposits |
|
|
(1,324 |
) |
|
|
5,504 |
|
|
|
11,784 |
|
|
|
7,652 |
|
Other current and long-term liabilities |
|
|
420 |
|
|
|
(1,811 |
) |
|
|
556 |
|
|
|
1,215 |
|
Net cash used in operating activities |
|
|
(131,242 |
) |
|
|
(65,126 |
) |
|
|
(380,241 |
) |
|
|
(230,763 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
||||||||
Capital expenditures |
|
|
(4,183 |
) |
|
|
(2,183 |
) |
|
|
(16,489 |
) |
|
|
(4,635 |
) |
Purchases of marketable securities |
|
|
(99,620 |
) |
|
|
(96,752 |
) |
|
|
(704,565 |
) |
|
|
(382,884 |
) |
Proceeds from maturities and calls of marketable securities |
|
|
140,277 |
|
|
|
— |
|
|
|
434,889 |
|
|
|
— |
|
Net cash provided by (used in) investing activities |
|
|
36,474 |
|
|
|
(98,935 |
) |
|
|
(286,165 |
) |
|
|
(387,519 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
||||||||
Payments of finance lease obligations |
|
|
(102 |
) |
|
|
(35 |
) |
|
|
(234 |
) |
|
|
(140 |
) |
Proceeds from convertible senior notes |
|
|
— |
|
|
|
— |
|
|
|
425,000 |
|
|
|
— |
|
Debt issuance costs |
|
|
— |
|
|
|
— |
|
|
|
(11,278 |
) |
|
|
— |
|
Purchase of capped call |
|
|
— |
|
|
|
— |
|
|
|
(52,318 |
) |
|
|
— |
|
Repayment of commercial loan |
|
|
— |
|
|
|
— |
|
|
|
(310 |
) |
|
|
(310 |
) |
Proceeds from issuance of common stock |
|
|
3,753 |
|
|
|
— |
|
|
|
103,326 |
|
|
|
500,000 |
|
Proceeds from issuance of common stock pursuant to stock options exercised |
|
|
— |
|
|
|
1,124 |
|
|
|
49 |
|
|
|
19,980 |
|
Withholding taxes paid on behalf of employees on net settled stock-based awards |
|
|
(505 |
) |
|
|
(7,622 |
) |
|
|
(3,984 |
) |
|
|
(23,401 |
) |
Transaction costs related to issuance of common stock |
|
|
(111 |
) |
|
|
(19 |
) |
|
|
(1,248 |
) |
|
|
(6,772 |
) |
Net cash provided by (used in) financing activities |
|
|
3,035 |
|
|
|
(6,552 |
) |
|
|
459,003 |
|
|
|
489,357 |
|
Net decrease in cash, cash equivalents and restricted cash |
|
|
(91,733 |
) |
|
|
(170,613 |
) |
|
|
(207,403 |
) |
|
|
(128,925 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
434,360 |
|
|
|
720,643 |
|
|
|
550,030 |
|
|
|
678,955 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
342,627 |
|
|
$ |
550,030 |
|
|
$ |
342,627 |
|
|
$ |
550,030 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents |
|
$ |
302,291 |
|
|
$ |
524,481 |
|
|
$ |
302,291 |
|
|
$ |
524,481 |
|
Restricted cash |
|
|
40,336 |
|
|
|
25,549 |
|
|
|
40,336 |
|
|
|
25,549 |
|
Cash, cash equivalents and restricted cash |
|
$ |
342,627 |
|
|
$ |
550,030 |
|
|
$ |
342,627 |
|
|
$ |
550,030 |
|
USE OF NON-GAAP FINANCIAL MEASURES
This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of net loss to Adjusted EBITDA for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net loss |
|
$ |
(150,820 |
) |
|
$ |
(80,797 |
) |
|
$ |
(500,152 |
) |
|
$ |
(352,899 |
) |
Income tax expense |
|
|
529 |
|
|
|
5 |
|
|
|
598 |
|
|
|
79 |
|
Interest expense |
|
|
3,206 |
|
|
|
6 |
|
|
|
12,130 |
|
|
|
25 |
|
Depreciation and amortization |
|
|
3,117 |
|
|
|
2,883 |
|
|
|
11,098 |
|
|
|
11,518 |
|
EBITDA |
|
|
(143,968 |
) |
|
|
(77,903 |
) |
|
|
(476,326 |
) |
|
|
(341,277 |
) |
Stock-based compensation |
|
|
11,221 |
|
|
|
13,101 |
|
|
|
45,709 |
|
|
|
61,805 |
|
Change in fair value of warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34,650 |
|
Adjusted EBITDA |
|
$ |
(132,747 |
) |
|
$ |
(64,802 |
) |
|
$ |
(430,617 |
) |
|
$ |
(244,822 |
) |
A reconciliation of selling, general and administrative expenses to non-GAAP selling, general and administrative expenses for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||
|
|
|
|
|
||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Selling, general and administrative expenses |
|
$ |
47,298 |
|
$ |
38,311 |
|
$ |
175,118 |
|
$ |
166,814 |
Stock-based compensation |
|
|
7,887 |
|
|
9,177 |
|
|
31,955 |
|
|
46,181 |
Non-GAAP selling, general and administrative expenses |
|
$ |
39,411 |
|
$ |
29,134 |
|
$ |
143,163 |
|
$ |
120,633 |
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||
|
|
|
|
|
||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Research and development expenses |
|
$ |
102,596 |
|
$ |
40,226 |
|
$ |
314,174 |
|
$ |
144,223 |
Stock-based compensation |
|
|
3,334 |
|
|
3,924 |
|
|
13,754 |
|
|
15,624 |
Non-GAAP research and development expenses |
|
$ |
99,262 |
|
$ |
36,302 |
|
$ |
300,420 |
|
$ |
128,599 |
The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the three months ending
|
|
|
Net cash used in operating activities |
|
|
Capital expenditures |
|
|
Free cash flow |
|
|
_______________
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006315/en/
For media inquiries:
Aleanna Crane - Vice President, Communications
Virgingalacticpress@virgingalactic.com
575.800.4422
For investor inquiries:
vg-ir@virgingalactic.com
949.774.7637
Source:
FAQ
What are Virgin Galactic's financial results for Q4 2022?
When is Virgin Galactic expected to launch commercial service?
What was the total net loss for Virgin Galactic in 2022?
How much cash did Virgin Galactic have at the end of 2022?